u still need PCT. 4 weeks of clomid should be fine, u just need to get your test restarted.
I am going to run an anavar only cycle. was able to get cheap bulk anavar powder. this will be my first cycle
Im going to run 40mg ED (20mg twice daily)
I am also going to run letrozole 1.25mg twice weekly to take care of any estrogen which may build up
Im going to run it for ten weeks with the usual liver protectants etc.
Do i still need nolvadex for PCT as i wont have much estrogen from running letro on cycle
Since i dont need nolvadex is there any PCT needed??
u still need PCT. 4 weeks of clomid should be fine, u just need to get your test restarted.
I'm running a 6wk cycle of var in about a week at 40mg. I was told not to run orals more than 6wks I might be wrong but don't you think 10wks is kinda long? This is also my first cycle
He should be fine with 10 weeks. its is a 17aa but the liver toxicity is overrated. There are much worse things that we put in our body's that we don't realize are much more toxic then oral steroids.
Some people may respond differently though so blood work is always advised.
I wouldn't use the letro unless you have to. Var by itself will kill your sex drive, add in letro and even viagra won't be able to help you. 40mg is a very low dose, I don't usually respond to anything less than 80, but then again, that's how I am with everything. Var is only mildly toxic, so liver protection should not be a concern as long as you are not drinking. PCT will be necessary, but it won't take much to recover.
I didn't even see that you were going to run letro. Anavar does not aromatize no need for the letro. My lidibo was fine when i took var. Take 50mg of proviron ed just in case your worried about your libido crashing.
Var doesn't aromatize so there is no need for letro.
letro is not needed as people say. Anavar gets processed through the kidneys more so than the liver. It also does not seem to be a cholesterol killer like some of the other orals, possibly due to less action in the liver, not sure. A little policosinol throughtout the cycle would not hurt though.
Very little mass maybe 5lbs if your lucky, good strength gains tough. The mass you put on though is easily maintainable and the fat you lose from anavar is easy to keep off unlike other steroids/PH's/DS
anavar does not cause fat loss, no steroid does.
i did 80mg for 8 weeks and gained quality mass (i think it was about 8 lbs.) and I just looked great, all veiny and cut.
It did screw up the libido for awhile though, i think it was blood pressure related
first thing i noticed is letro. Its not needed.
2nd thing i noticed is 40mg ed is a low dose. How about 60?
Var is mild, I think you could push to 8 weeks but nothing wrong with 6 especially for a first cycle. Suppression shouldn't be too bad so PCT should be a breeze.
Mostly answered PM's
Don't post on my profile, I don't read that stuff, PM me instead
<------ Hard to believe, but I wasn't on any anabolics in the avatar shot
Lovejoy JC, Bray GA, Greeson CS, Klemperer M, Morris J, Partington C, Tulley R. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men. Int J Obes Relat Metab Disord. 1995;19(9):614-24.
OBJECTIVE: To compare the effects of testosterone enanthate (TE), anabolic steroid (AS) or placebo (PL) on regional fat distribution and health risk factors in obese middle-aged men undergoing weight loss by dietary means. DESIGN: Randomized, double-blind, placebo-controlled clinical trial, carried out for 9 months with primary assessments at 3 month intervals. Due to adverse blood lipid changes, the AS group was switched from oral oxandrolone (ASOX) to parenteral nandrolone decaoate (ASND) after the 3 month assessment point. SUBJECTS: Thirty healthy, obese men, aged 40-60 years, with serum testosterone (T) levels in the low-normal range (2-5 ng/mL). MAIN OUTCOME MEASURES: Abdominal fat distribution and thigh muscle volume by CT scan, body composition by dual energy X-ray absorptiometry (DEXA), insulin sensitivity by the Minimal Model method, blood lipids, blood chemistry, blood pressure, thyroid hormones and urological parameters. RESULTS: After 3 months, there was a significantly greater decrease in subcutaneous (SQ) abdominal fat in the ASOX group compared to the TE and PL groups although body weight changes did not differ by treatment group. There was also a tendency for the ASOX group to exhibit greater losses in visceral fat, and the absolute level of visceral fat in this group was significantly lower at 3 months than in the TE and PL groups. There were significant main effects of treatment at 3 months on serum T and free T (increased in the TE group and decreased in the ASOX group) and on thyroid hormone parameters (T4 and T3 resin uptake significantly decreased in the ASOX group compared with the other two groups). There was a significant decrease in HDL-C, and increase in LDL-C in the ASOX group, which led to their being switched to the parenteral nandrolone decanoate (ASND) after 3 months. ASND had opposite effects on visceral fat from ASOX, producing a significant increase from 3 to 9 months while continuing to decrease SQ abdominal fat. ASND treatment also decreased thigh muscle area, while ASOX treatment increased high muscle. ASND reversed the effects of ASOX on lipoproteins and thyroid hormones. The previously reported effect of T to decrease visceral fat was not observed, in fact, visceral fat in the TE group increased slightly from 3 to 9 months, although SQ fat continued to decrease. Neither TE nor AS treatment resulted in any change in urologic parameters. CONCLUSIONS: Oral oxandrolone decreased SQ abdominal fat more than TE or weight loss alone and also tended to produce favorable changes in visceral fat. TE and ASND injections given every 2 weeks had similar effects to weight loss alone on regional body fat. Most of the beneficial effects observed on metabolic and cardiovascular risk factors were due to weight loss per se. These results suggest that SQ and visceral abdominal fat can be independently modulated by androgens and that at least some anabolic steroids are capable of influencing abdominal fat.
Schroeder ET, Zheng L, Ong MD, Martinez C, Flores C, Stewart Y, Azen C, Sattler FR. Effects of androgen therapy on adipose tissue and metabolism in older men. J Clin Endocrinol Metab. 2004;89(10):4863-72.
We investigated the effects of oxandrolone on regional fat compartments and markers of metabolism. Thirty-two 60- to 87-yr-old men (body mass index, 28.1 +/- 3.4 kg/m(2)) were randomized to oxandrolone (20 mg/d; n = 20) or matching placebo (n = 12) treatment for 12 wk. Oxandrolone reduced total (-1.8 +/- 1.0 kg; P < 0.001), trunk (-1.2 +/- 0.6 kg; P < 0.001), and appendicular (-0.6 +/- 0.6 kg; P < 0.001) fat, as determined by dual energy x-ray absorptiometry. The changes in total and trunk fat were greater (P < 0.001) than the changes with placebo. By magnetic resonance imaging, visceral adipose tissue decreased (-20.9 +/- 12 cm(2); P < 0.001), abdominal sc adipose tissue (SAT) declined (-10.7 +/- 12.1 cm(2); P = 0.043), the ratio VAT/SAT declined from 0.57 +/- 0.23 to 0.49 +/- 0.19 (P = 0.002), and proximal and distal thigh SC fat declined [-8.3 +/- 6.7 cm(2) (P < 0.001) and -2.2 +/- 3.0 kg (P = 0.004), respectively]. Changes in proximal and distal thigh SC fat with oxandrolone were different than with placebo (P = 0.018 and P = 0.059). A marker of insulin sensitivity (quantitative insulin sensitivity check index) improved with oxandrolone by 0.0041 +/- 0.0071 (P = 0.018) at study wk 12. Changes in total fat, abdominal SAT, and proximal extremity SC fat were correlated with changes in fasting insulin from baseline to study wk 12 (r >or= 0.45; P < 0.05). Losses of total fat and SAT were greater in men with baseline testosterone of 10.4 nmol/liter or less (<or= 300 ng/dl) than in those with higher levels [-2.5 +/- 1.1 vs. -1.5 +/- 0.8 kg (P = 0.036) and -24.1 +/- 14.3 vs. -2.9 +/- 21.3 cm(2) (P = 0.03), respectively]. Twelve weeks after discontinuing oxandrolone, 83% of the reductions in total, trunk, and extremity fat by dual energy x-ray absorptiometry scanning were sustained (P < 0.02). Androgen therapy, therefore, produced significant and durable reductions in regional abdominal and peripheral adipose tissue that were associated with improvements in estimates of insulin sensitivity. However, high-density lipoprotein cholesterol decreased by -0.49 +/- 0.21 mmol/liter and directly measured low-density lipoprotein cholesterol increased by 0.57 +/- 0.67 mmol/liter and non-high-density lipoprotein cholesterol increased by 0.54 +/- 0.97 mmol/liter (P < 0.03 for each) during treatment with oxandrolone; these changes were largely reversible. Thus, therapy with an androgen that does not adversely affect lipids may be beneficial for some components of the metabolic syndrome in overweight older men with low testosterone levels.
As said above, NO letro is needed.
I personally would not run this cycle, your first cycle should be a good one and you should really consider running test with it. 2 shots a week for a total of 500mg ... you will not regret listening to me! I've only used HCG and novla for PCT and recovered fine ... I wont take clomid
its also interesting that I am hearing people say take more than 40mg ... maybe because you plan to take it by itself? The usual dose for var is 25, 40, or 50mg's ... never really heard people advising to take more. Your liver really isn't the biggest concern while taking anavar, its your lipids etc you need to worry about
Color me surprised. I guess the UG powder from China really was crap because I never saw any fat loss.